|
CALGARY, ALBERTA--(Marketwire - Nov. 2, 2010) - Stem Cell Therapeutics Corp. (TSX VENTURE:SSS) ("SCT" or the "Company") is pleased to report that shareholders and brokers have completed the execution of 12,210,000 warrants and the Company is in receipt of $1,822,000 from the proceeds of the warrant exercise. The warrants were part of the financing completed by the Company on October 29, 2009. |
